Dezocine for Prevention of Catheter-related Bladder Discomfort

• Status: Completed
• Trial end date: 2017-10-30
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jian-jun Yang
• Treatments: Dezocine; Flurbiprofen; Flurbiprofen axetil

Criteria

Inclusion Criteria:

1. Adult (>/=18)

2. Male or female

3. Patients scheduled for abdominal surgery

4. Undergoing catheterization

5. Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2

Exclusion Criteria:

1. Patient with bladder outflow obstruction

2. Patient with overactive bladder (frequency greater than three times per night or more than eight times per 24 h)

3. Patient with multisystemic diseases (central nervous system, cardiovascular system hepatic, psychiatric, and end-stage renal diseases)

4. Patient with chemical substance abuse

5. Patient with chronic pain

6. Patient with morbid obesity

7. Patient needs for urgent intervention